Company information
- Ticker
- DCGO
- Country
- United States
- Sector
- Health Care
- Industry
- Providers
DocGo Business Summary
DocGo Inc. (DCGO) operates as a provider of last-mile mobile health services and integrated medical mobility solutions, generating revenue through a combination of multi-year service contracts with health systems and insurance payers, as well as fee-for-service medical transportation. Following a strategic pivot in 2025 to sunset large-scale municipal migrant-related projects, the company’s business model is now centered on two primary segments: Medical Transportation, which utilizes a proprietary AI-driven logistics platform for ambulance and non-emergency medical transport (NEMT), and Mobile Health Services, which provides high-acuity clinical care, chronic disease management, and remote patient monitoring. The late 2025 acquisition of SteadyMD significantly expanded its virtual care reach, allowing for a hybrid "boots-on-the-ground" and digital delivery model. In the competitive landscape, DocGo contends with American Medical Response (AMR) and Acadian Ambulance in the transport sector, ModivCare in NEMT logistics, and DispatchHealth in mobile urgent care. DocGo distinguishes itself by bridging the gap between traditional hospital settings and home-based care through its massive vehicle fleet and proprietary software infrastructure. The company is led by Chief Executive Officer Lee Bienstock, who assumed the role in late 2023 after serving as President and COO; he brings a decade of operational pedigree from Google, where he led global enterprise partnerships. He is supported by CFO and Treasurer Norman Rosenberg, a Chartered Financial Analyst with extensive experience in capital markets and divestitures at AmTrust Financial and IDT Telecom, and CTO Hawk Newton, a veteran software architect who has led the development of the company’s core logistics technology since 2017. DocGo was founded in 2015 by Stan Vashovsky, a serial healthcare entrepreneur who previously served as CEO. The Board of Directors is chaired by Dr. Stephen Klasko, the former CEO of Jefferson Health and a prominent figure in health system transformation. Notable institutional backing includes significant positions held by P.A.W. Capital Corp and other large money managers, reflecting a majority institutional ownership stake as the leadership focuses on achieving consistent EBITDA profitability through high-margin virtual care and longitudinal health services.